Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Licenses Key Microarray, Gene Expression Patents to Agilent

NEW YORK, Nov. 5 – Incyte Genomics said Monday that it had licensed its main microarray and gene expression patents to Agilent Technologies, a manufacturer of printed DNA microarrays.

Under the terms of the licensing agreements, Incyte will provide Agilent with its patents for nucleic acid linear amplification, the manufacture and use of DNA microarrays, and the use of gene expression arrays in cancer research and diagnosis. 

Incyte has also exclusively licensed to Agilent its patent portfolio for inkjet array manufacture, including patents for in situ  synthesis of nucleic acid microarrays. 

"We are pleased to add the Incyte patents to the already extensive portfolio of Agilent patents and patent licenses," Barney Saunders, vice president and general manager of Agilent's Bio-Research Solutions, said in a statement.

"These patents will consolidate and strengthen Agilent's position as a major manufacturer of printed DNA microarrays and as a supplier of reagents and kits for sample preparation," Saunders said. 

Financial terms of the deal were not disclosed.

In January, Agilent opened a 15,000-square-foot DNA microarray production facility as part of its efforts to expand its microarray manufacturing program, which included plans to ship over one million microarrays per year by 2002.

As part of that effort, Agilent also previously signed a deal for access to Incyte’s cDNA clones and its Lifeseq data for use on the company’s off-the-shelf arrays.

Both Agilent and Incyte are based in Palo Alto, Calif.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.